Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Neonatology|April 29, 2024
Machine Learning to Improve Accuracy of Transcutaneous BilirubinometryDaisaku Morimoto, Yosuke Washio, Kana Fukuda, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 16, 2024
Real-World Comparative Analysis of Trastuzumab Originator and Biosimilars: Safety, Efficacy, and Cost EffectivenessTomoka Mamori, Maki Tanioka, Kenji Takada, et al.
International Journal of Clinical Oncology|September 1, 2021
Clinical management and outcomes associated with etoposide, doxorubicin, and cisplatin plus mitotane treatment in metastatic adrenocortical carcinoma: a single institute experienceMasaki Uchihara, Maki Tanioka, Yuki Kojima, et al.
Genes, Chromosomes & Cancer|January 1, 2003
Establishment of the acute myeloid leukemia cell line Kasumi-6 from a patient with a dominant-negative mutation in the DNA-binding region of the C/EBPalpha geneHiroya Asou, Adrian F Gombart, Seisho Takeuchi, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 7, 2024
Long short-term memory algorithm for personalized tacrolimus dosing: A simple and effective time series forecasting approach post-lung transplantationHaruki Choshi, Kentaroh Miyoshi, Maki Tanioka, et al.
Medical Oncology (Northwood, London, England)|July 7, 2017
Cisplatin with dose-dense paclitaxel before and after radical hysterectomy for locally advanced cervical cancer: a prospective multicenter phase II trial with a dose-finding studyMaki Tanioka, Satoshi Yamaguchi, Muneaki Shimada, et al.
Cancer Treatment and Research Communications|June 13, 2022
Case report: Response to platinum agents and poly (adenosine diphosphate-ribose) polymerase inhibitor in a patient with BRCA1 c.5096G>A (R1699Q) intermediate-risk variantAyumi Saito, Maki Tanioka, Makoto Hirata, et al.
Gynecologic Oncology|October 1, 2013
Applicability of the concept of "platinum sensitivity" to recurrent endometrial cancer: the SGSG-012/GOTIC-004/Intergroup studyShoji Nagao, Shin Nishio, Hirofumi Michimae, et al.
Case Reports in Oncological Medicine|March 25, 2020
Response to Dabrafenib and Trametinib of a Patient with Metaplastic Breast Carcinoma Harboring a BRAF V600E MutationTakuji Seo, Emi Noguchi, Masayuki Yoshida, et al.
Cancer Science|December 8, 2011
A Phase I, dose-finding and pharmacokinetic study of olaparib (AZD2281) in Japanese patients with advanced solid tumorsNoboru Yamamoto, Hiroshi Nokihara, Yasuhide Yamada, et al.
Pageof 5